The heterogeneity of Type IIA von Willebrand disease: Studies with protease inhibitors - Batlle, J; López-Fernandez, M F; Campos, M; Justiga, B; Berges, C; Navarro, J L; Diaz-Cremades, J M; Casper, C K; Dent, J D; Ruggeri, Z M; Zimmerman, T S (Blood, 1986)